Loading...

SWK Holdings Corporation

SWKHNASDAQ
Financial ServicesAsset Management
$14.28
$0.15(1.06%)

SWK Holdings Corporation (SWKH) Stock Overview

Explore SWK Holdings Corporation’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
19.14%
19.14%
Profit Growth
$1.49
15.10%
EPS Growth
$1.49
13.49%
Operating Margin
47.20%
20.91%
ROE
6.37%
15.10%
Dividend Yield
0.00%
Analyst Recommendations data is not available for SWKHAnalyst Recommendations details for SWKH are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

SWK Holdings Corporation, a specialty finance company that focuses on the healthcare sector. It operates in two segments, Finance Receivables and Pharmaceutical Development. The company provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. It also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. In addition, the company engages in the pharmaceutical development, formulation and manufacturing, and licensing business through the Peptelligence platform. Further, it intends to out-license its internal product pipeline to create novel formulations using its proprietary technology to develop treatments for patients and caregivers. The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was founded in 1996 and is headquartered in Dallas, Texas.

CEO

Mr. Jody. D Staggs

Employees

24

Headquarters

14755 Preston Road, Dallas, TX

Founded

1999

Frequently Asked Questions